What Is the Impact of Prior TNF Inhibitor Treatment on the Time to Achieve Low Disease Activity and the Durability of Low Disease Activity? Real-world Results Based on 17 858 European Patients with Axial Spondyloarthritis Initiating a TNF
04/12/2024
Heberg J, Georgiadis S, Pons M, Loft A, Michelsen B, Linde L, DiGuiseppe D, Rasmussen S, Kazemi M, Macfarlane G, Jones G, Laas K, Vorobjov S, Castrejon I, Rotar Z, Perdan-Pikmajer K, Šenolt L, Baranová J, Glintborg B, Ciurea A, Bernardes M, Valente P, Gudbjornsson B, Gröndal G, Bakland G, Codreanu C, Mogosan C, Iannone F, Caporali R, Karlsson Wallman J, Rantalaiho V, Peltomaa R, Pavelka K, Horak P, Esperança Almeida D, Rodrigues S, Oernbjerg L, Ostergaard M, Hetland M
ACR 2024
Oral presentation
https://acrabstracts.org/abstract/what-is-the-impact-of-prior-tnf-inhibitor-treatment-on-the-time-to-achieve-low-disease-activity-and-the-durability-of-low-disease-activity-real-world-results-based-on-17-858-european-patients-with-ax/